ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2024

The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancer.

Philip J Saylor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.